AZN - Ontario court approves AstraZeneca/Fusion acquisition plan
2024-05-31 18:06:40 ET
More on AstraZeneca, Fusion Pharmaceuticals, etc.
- AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, I'm Pausing For Breath
- AstraZeneca: A Triple Shot Of Income, Growth, And Value
- AstraZeneca: Strong In A Weak Market
- Amgen wins approval of first biosimilar of AstraZeneca's Soliris
- AstraZeneca touts PCSK9 inhibitor in lowering LDL cholesterol when added to statin